Jiamin Ge Selected Research

propargylamine

1/2022	HDAC1/MAO-B dual inhibitors against Alzheimer's disease: Design, synthesis and biological evaluation of N-propargylamine-hydroxamic acid/o-aminobenzamide hybrids.
1/2021	N-Propargylamine-hydroxypyridinone hybrids as multitarget agents for the treatment of Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiamin Ge Research Topics

Disease

2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2021
1	Inflammation (Inflammations) 03/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021

Drug/Important Bio-Agent (IBA)

2	propargylamineIBA 01/2022 - 01/2021
1	Hydroxamic Acids (Hydroxamic Acid)IBA 01/2022
1	Biological ProductsIBA 01/2022
1	Monoamine Oxidase (MAO)IBA 01/2022
1	Pharmaceutical PreparationsIBA 03/2021
1	AlkaloidsIBA 03/2021
1	LigandsIBA 01/2021

Therapy/Procedure

1	Therapeutics 01/2022